Unique ID issued by UMIN | UMIN000008690 |
---|---|
Receipt number | R000010216 |
Scientific Title | Efficacy of automated carbon dioxide insufflation and IV Buscopan as a muscle relaxant in computed tomography colonography. |
Date of disclosure of the study information | 2012/08/15 |
Last modified on | 2014/12/27 10:20:48 |
Efficacy of automated carbon dioxide insufflation and IV Buscopan as a muscle relaxant in computed tomography colonography.
Efficacy of automated CO2 insufflation and IV Buscopan in CT colonography
Efficacy of automated carbon dioxide insufflation and IV Buscopan as a muscle relaxant in computed tomography colonography.
Efficacy of automated CO2 insufflation and IV Buscopan in CT colonography
Japan |
Healthy individual
Gastroenterology | Radiology |
Others
NO
Evaluation of efficacy of automated carbon dioxide insufflation and IV Buscopan as a muscle relaxant in computed tomography colonography
Efficacy
Confirmatory
Explanatory
Not applicable
Assessment of colon and small intestine distension per segment using a 4-point scale (prone and supine).
Data on perceived burden of CT colonography were collected using visual analogue scale (VAS) and a questionnaire.
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
Central registration
4
Diagnosis
Medicine | Device,equipment |
Automated carbon dioxide insufflation with intravenous injection of butyl scopolamine (Buscopan)
Manual carbon dioxide insufflation without butyl scopolamine (Buscopan)
Manual carbon dioxide insufflation with intravenous injection of butyl scopolamine (Buscopan)
Automated carbon dioxide insufflation without butyl scopolamine (Buscopan)
40 | years-old | <= |
Not applicable |
Male and Female
1) Healthy individual.
2) Major functions of organs of the subjects are in a good condition.
3) Aged 40 years or older.
4) Signed informed consent forms are obtained by the patients.
1) Patients with inflammatory bowel disease.
2) Fulfillment of clinical criteria for diagnosis of FAP or HNPCC (Amsterdam criteria).
3) Contraindication for using Buscopan.
4) Previous colorectal surgery.
5) Gastric or intestinal stenosis, abdominal adhesions, bowel obstruction or perforation, toxic megacolon.
6) Evidence of an increased risk in carrying out bowel preparation or CTC exams.
7) Possibility of pregnancy.
8) Patients with psychological conditions that contraindicate colonoscopy or make them irrelevant to participate in the trial.
9) Claustrophobia.
10) Severe deafness.
11) Subjects whose eligibility for this clinical trial is not appropriate by other reasons.
200
1st name | |
Middle name | |
Last name | Koichi Nagata M.D PhD |
Kameda Medical Center Makuhari
Department of Gastroenterology
1-3 CD2, Nakase, Mihama-ku, Chiba, 261-8501, Japan
043-296-2711
Nagata7@aol.com
1st name | |
Middle name | |
Last name | Koichi Nagata M.D PhD |
Kameda Medical Center Makuhari
Department of Gastroenterology
1-3 CD2, Nakase, Mihama-ku, Chiba, 261-8501, Japan
043-296-2711
Nagata7@aol.com
Kameda Medical Center Makuhari
Kameda Medical Center Makuhari
Self funding
None
EIDIA Co., Ltd.
NO
亀田メディカルセンター幕張(千葉県)
2012 | Year | 08 | Month | 15 | Day |
Published
http://www.ajronline.org/doi/abs/10.2214/AJR.14.12772
OBJECTIVE
The purpose of this article is to evaluate the efficacy of IV hyoscine butylbromide as a bowel relaxant and automated carbon dioxide insufflation in CT colonography in terms of colonic distention and perceived burden.
SUBJECTS AND METHODS
Two hundred twenty-four participants were randomly allocated to one of four groups: control (no bowel relaxant and IV saline placebo before CT colonography with manual carbon dioxide insufflation), hyoscine butylbromide (IV hyoscine butylbromide before examination with manual carbon dioxide insufflation), automated (no bowel relaxant before examination with automated carbon dioxide insufflation), and combined (hyoscine butylbromide before examination with automated carbon dioxide insufflation). The degree of colonic distention on a 4-point scale, examination time, and participants' satisfaction, as measured by their responses to a questionnaire, were assessed.
RESULTS
The mean distention grades of all the colonic segments and both positions were 3.22 in the control group, 3.28 in the hyoscine butylbromide group, 3.77 in the automated group, and 3.74 in the combined group. Compared with manual carbon dioxide insufflation, automated carbon dioxide insufflation significantly improved the clinical adequacy of colonic distention and shortened examination time. No statistically significant difference was seen in the clinical adequacy of distention between participants who received hyoscine butylbromide and those who did not, or in examination time. Overall, the participants' experiences were not different.
CONCLUSION
Colonic distention was statistically significantly improved by automated carbon dioxide insufflation, but not by the administration of hyoscine butylbromide. The participants' tolerance was similar in each group.
Read More: http://www.ajronline.org/doi/abs/10.2214/AJR.14.12772
Main results already published
2012 | Year | 06 | Month | 01 | Day |
2012 | Year | 07 | Month | 01 | Day |
2013 | Year | 12 | Month | 31 | Day |
2014 | Year | 01 | Month | 31 | Day |
2014 | Year | 02 | Month | 28 | Day |
2014 | Year | 06 | Month | 30 | Day |
2012 | Year | 08 | Month | 15 | Day |
2014 | Year | 12 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010216
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |